|
BioAxone Therapeutic is a privately held
neuroscience company based in Montreal, whose
goal is to develop and commercialize products
which meet significant medical needs in spinal
cord injury and retinal eye diseases, such as
macular degeneration and glaucoma. The Company
specializes in the development and
commercialization of proprietary technologies
that target Rho signaling pathway. Other
products in the development stage are
second-generation recombinant protein compounds.
The Company also has small molecule Rho kinase
inhibitors under preclinical investigation.
|
.gif){kind=spacer}
